A History of Prior Bare Metal Stent Restenosis Is Associated with Major Adverse Cardiac Events in Subsequent Bare Metal Stenting of de novo Coronary Lesions

被引:2
|
作者
Ferguson, Michael A. [1 ]
Needleman, Matthew
Mitchell, Eric S. [2 ]
Carter, Luther I. [3 ]
Bustamante, Alexander I.
Love, Kathleen M. [3 ]
Curran, Michael J.
机构
[1] Natl Naval Med Ctr, Dept Cardiol, Bethesda, MD 20889 USA
[2] USN, Med Ctr, Portsmouth, VA USA
[3] USN, Med Ctr, San Diego, CA 92152 USA
关键词
Coronary lesion; Bare metal stent; Restenosis; Major adverse cardiac events; INTERVENTION;
D O I
10.1159/000319472
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To investigate the risk of major adverse cardiac events (MACE) in patients with a history of bare metal stent (BMS) restenosis who undergo subsequent bare metal stenting of a geographically distinct, de novo coronary lesion. Methods: We conducted a retrospective review of 72 BMS procedures performed in geographically distinct, de novo coronary lesions in patients with a history of previous BMS placement at least 3 months prior to the second, index stent procedure. Patients with a history of in-stent restenosis (ISR) were compared with those who had no ISR in their initial stent. Results: Restenosis in the initial BMS was associated with a significant increase in MACE after placement of the index BMS (OR 20.0, 95% CI 3.86-103.58, p < 0.0001). This association was independent of traditional clinical and angio-graphic risk factors for restenosis. Conclusions: Restenosis of a previously placed BMS is strongly associated with MACE after placement of a subsequent BMS in a de novo coronary lesion. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:190 / 193
页数:4
相关论文
共 50 条
  • [41] Seven-Year Clinical Outcomes of Unprotected Left Main Coronary Artery Stenting With Drug-Eluting Stent and Bare-Metal Stent
    Kubo, Shunsuke
    Kadota, Kazushige
    Shimada, Takenobu
    Ozaki, Masatomo
    Ichinohe, Tahei
    Eguchi, Haruki
    Miyake, Koshi
    Hyodo, Yusuke
    Saito, Naoki
    Otsuji, Hideaki
    Otsuru, Suguru
    Hasegawa, Daiji
    Shigemoto, Yoshikazu
    Habara, Seiji
    Tada, Takeshi
    Tanaka, Hiroyuki
    Fuku, Yasushi
    Katoh, Harumi
    Yamamoto, Hiroyuki
    Fujii, Satoki
    Goto, Tsuyoshi
    Mitsudo, Kazuaki
    CIRCULATION JOURNAL, 2013, 77 (10) : 2497 - 2504
  • [42] Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-human randomised trial, balloon first vs. stent first
    Gutierrez-Chico, Juan Luis
    van Geuns, Robert Jan
    Koch, Karel T.
    Koolen, Jacques J.
    Duckers, Henricus
    Regar, Evelyn
    Serruys, Patrick W.
    EUROINTERVENTION, 2011, 7 (06) : 711 - 722
  • [43] Difference in Optical Coherence Tomography Findings of Very Late In-Stent Restenosis Lesions Between After Bare-Metal Stent and Sirolimus-Eluting Stent Implantation
    Tada, Takeshi
    Kadota, Kazushige
    Habara, Seiji
    Tanaka, Hiroyuki
    Fuku, Yasushi
    Goto, Tsuyoshi
    Mitsudo, Kazuaki
    CIRCULATION, 2014, 130
  • [44] Comparison of Drug-Eluting Stent With Bare Metal Stent for Distal De Novo Unprotected Left Main Coronary Artery Stenosis A Propensity Score-Matched Cohort Study
    Hsueh, Shu-Kai
    Wu, Chiung-Jen
    Fang, Hsiu-Yu
    Hsieh, Yuan-Kai
    Fang, Chih-Yuan
    Chen, Chien-Jen
    Chen, Shyh-Ming
    Yang, Cheng-Hsu
    Yip, Hon-Kan
    Chen, Mien-Cheng
    Fu, Morgan
    Cheng, Cheng-I
    CIRCULATION JOURNAL, 2011, 75 (02) : 290 - 298
  • [45] Difference of Neoatherosclerosis Pattern in Lesions With In-Stent Restenosis Among Bare-Metal, First and Second Generation Drug-Eluting Stents
    Nakamura, Daisuke
    Nishino, Masami
    Yasumura, Keisuke
    Yasumoto, Koji
    Tanaka, Akihiro
    Mori, Naoki
    Yano, Masamichi
    Egami, Yasuyuki
    Shutta, Ryu
    Tanouchi, Jun
    CIRCULATION, 2017, 136
  • [46] INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial
    Francesco Burzotta
    Marta Francesca Brancati
    Carlo Trani
    Italo Porto
    Antonella Tommasino
    Gianluigi De Maria
    Giampaolo Niccoli
    Antonio Maria Leone
    Valentina Coluccia
    Giovanni Schiavoni
    Filippo Crea
    Trials, 13
  • [47] Randomized comparison between bare-metal stent plus colchicine versus drug-eluting stent alone in prevention of clinical adverse events after percutaneous coronary intervention
    Correa-Sadouet, Camila
    Rodriguez-Granillo, A. Matias
    Gallardo, Camila
    Mieres, Juan
    Fontana, Lucia
    Curotto, Maria Valeria
    Wainer, Pedro
    Allende, N. Gustavo
    Fernandez-Pereira, Carlos
    M Vetulli, Hector
    de la Hoz, R. Perez
    Kastrati, Adnan
    Rodriguez, Alfredo E.
    FUTURE CARDIOLOGY, 2020, 17 (04) : 539 - 547
  • [48] Impact of drug-eluting balloon (pre- or post-) dilation on neointima formation in de novo lesions treated by bare-metal stent: the IN-PACT CORO trial
    Burzotta, Francesco
    Brancati, Marta Francesca
    Trani, Carlo
    Pirozzolo, Giancarlo
    De Maria, Gianluigi
    Leone, Antonio Maria
    Niccoli, Giampaolo
    Porto, Italo
    Prati, Francesco
    Crea, Filippo
    HEART AND VESSELS, 2016, 31 (05) : 677 - 686
  • [49] Intra-Individual Changes of Active Matrix Metalloproteinase-9 Are Associated with Clinical In-Stent Restenosis of Bare Metal Stents
    Tarr, G. P.
    Williams, M. J. A.
    Wilkins, G. T.
    Chen, V. H. T.
    Phillips, L. V.
    van Rij, A. M.
    Jones, G. T.
    CARDIOLOGY, 2013, 124 (01) : 28 - 35
  • [50] Efficacy of intramuscular methyl prednisolone in preventing restenosis after coronary artery stenting with bare-metal stainless steel stent: a double-blind, randomised, controlled clinical trial
    Namdari, M.
    Ghafarzadeh, M.
    Nikoo, Ma
    CARDIOVASCULAR JOURNAL OF AFRICA, 2011, 22 (02) : 67 - 69